[EN] 2-ARYLNAPHTHYRIDIN-4-ONES AS POTENT ANTITUMOR AGENTS TARGETING TUMORIGENIC CELL LINES<br/>[FR] 2-ARYLNAPHTYRIDIN-4-ONES EN TANT QU'AGENTS ANTITUMORAUX PUISSANTS CIBLANT DES LIGNÉES CELLULAIRES TUMORIGÈNES
申请人:KUO SHENG-CHU
公开号:WO2014179401A1
公开(公告)日:2014-11-06
In order to search for new antitumor drug candidates from 2-arylnaphthyridin-4-ones (ANs), we have designed and synthesized a series of 3 '-hydroxy or 6-hydroxy derivatives of ANs. Following the antitumor activity screening, most of these compounds were found to exhibit significant activity. Among them, 2-(3-hydroxyphenyl)-5-methyl-1,8-naphthyridin-4(1H)-one (67) was the most promising. In a preliminary action mechanism study, the treatment of Hep3B hepatoma cells with compound (67) reveals that its mechanism of action is affect on microtubule and metastasis-related proteins. Then, the corresponding phosphate prodrug (86) of compound (67) was tested against Hep3B xenograft nude mice model for antitumor activity.
为了从2-芳基萘啉并酮(ANs)中寻找新的抗肿瘤药物候选物,我们设计并合成了一系列ANs的3'-羟基或6-羟基衍生物。经过抗肿瘤活性筛选,发现其中大多数化合物表现出显著的活性。其中,2-(3-羟基苯基)-5-甲基-1,8-萘啉-4(1H)-酮(67)是最有前途的。在初步的作用机制研究中,用化合物(67)处理Hep3B肝癌细胞表明其作用机制影响微管和与转移相关的蛋白质。然后,化合物(67)的相应磷酸酯前药(86)被用于对Hep3B异种移植裸鼠模型进行抗肿瘤活性测试。